Increased levels of atherosclerosis markers in salt-sensitive hypertension

Maria Larrousse1, Ernesto Bragulat, Marta Segarra

  • 1Hypertension Unit, Department of Internal Medicine, Hospital Clínic, Villaroel 170, 08036 Barcelona, Spain.

Insights

Salt-sensitive hypertension is linked to higher inflammation markers like selectins and chemokines, and impaired blood vessel function. These changes may explain increased cardiovascular risk in these patients.

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Endothelial Function Studies

Background:

  • Salt sensitivity in essential hypertension is a known risk factor for endothelial dysfunction and cardiovascular events.
  • Understanding the molecular markers associated with salt sensitivity is crucial for risk stratification and targeted therapies.

Purpose of the Study:

  • To investigate serum markers of atherosclerosis and endothelial function in salt-sensitive versus salt-resistant hypertensive patients.
  • To correlate these markers with salt intake and blood pressure responses.

Main Methods:

  • Classified 43 hypertensive patients into salt-sensitive (n=20) and salt-resistant (n=23) groups based on 24-h blood pressure response to low and high salt diets.
  • Assessed endothelium-dependent and independent vasodilation.
  • Measured serum levels of inflammatory markers (CRP, sICAM-1, sVCAM-1, selectins, IL-6, MCP-1), matrix metalloproteinases (MMP-1, -2, -9), and tissue inhibitor of metalloproteinases (TIMP-1).

Main Results:

  • Salt-sensitive hypertensives exhibited significantly higher levels of p-selectin, e-selectin, and monocyte chemotactic protein-1 (MCP-1) compared to salt-resistant individuals.
  • Reduced serum levels of matrix metalloproteinase-9 (MMP-9) and increased tissue inhibitor of metalloproteinases-1 (TIMP-1) were observed in salt-sensitive patients.
  • Endothelium-dependent vasodilation was significantly impaired in salt-sensitive hypertensives.

Conclusions:

  • Salt-sensitive hypertension is characterized by distinct alterations in inflammatory markers (selectins, chemokines) and vascular remodeling proteins (MMP-9, TIMP-1).
  • Impaired endothelium-dependent vasodilation is a key feature of salt sensitivity.
  • These molecular and functional changes may underlie the increased target organ damage and cardiovascular risk associated with salt-sensitive hypertension.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...